These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


972 related items for PubMed ID: 25422384

  • 1. External validation of blood eosinophils, FE(NO) and serum periostin as surrogates for sputum eosinophils in asthma.
    Wagener AH, de Nijs SB, Lutter R, Sousa AR, Weersink EJ, Bel EH, Sterk PJ.
    Thorax; 2015 Feb; 70(2):115-20. PubMed ID: 25422384
    [Abstract] [Full Text] [Related]

  • 2. Periostin levels and eosinophilic inflammation in poorly-controlled asthma.
    Simpson JL, Yang IA, Upham JW, Reynolds PN, Hodge S, James AL, Jenkins C, Peters MJ, Jia G, Holweg CT, Gibson PG.
    BMC Pulm Med; 2016 Apr 30; 16(1):67. PubMed ID: 27130294
    [Abstract] [Full Text] [Related]

  • 3. Type 2 innate lymphoid cells: A novel biomarker of eosinophilic airway inflammation in patients with mild to moderate asthma.
    Liu T, Wu J, Zhao J, Wang J, Zhang Y, Liu L, Cao L, Liu Y, Dong L.
    Respir Med; 2015 Nov 30; 109(11):1391-6. PubMed ID: 26459159
    [Abstract] [Full Text] [Related]

  • 4. Periostin is a systemic biomarker of eosinophilic airway inflammation in asthmatic patients.
    Jia G, Erickson RW, Choy DF, Mosesova S, Wu LC, Solberg OD, Shikotra A, Carter R, Audusseau S, Hamid Q, Bradding P, Fahy JV, Woodruff PG, Harris JM, Arron JR, Bronchoscopic Exploratory Research Study of Biomarkers in Corticosteroid-refractory Asthma (BOBCAT) Study Group.
    J Allergy Clin Immunol; 2012 Sep 30; 130(3):647-654.e10. PubMed ID: 22857879
    [Abstract] [Full Text] [Related]

  • 5. Diagnostic accuracy of minimally invasive markers for detection of airway eosinophilia in asthma: a systematic review and meta-analysis.
    Korevaar DA, Westerhof GA, Wang J, Cohen JF, Spijker R, Sterk PJ, Bel EH, Bossuyt PM.
    Lancet Respir Med; 2015 Apr 30; 3(4):290-300. PubMed ID: 25801413
    [Abstract] [Full Text] [Related]

  • 6. Biomarkers to identify sputum eosinophilia in different adult asthma phenotypes.
    Westerhof GA, Korevaar DA, Amelink M, de Nijs SB, de Groot JC, Wang J, Weersink EJ, ten Brinke A, Bossuyt PM, Bel EH.
    Eur Respir J; 2015 Sep 30; 46(3):688-96. PubMed ID: 26113672
    [Abstract] [Full Text] [Related]

  • 7. Full blood count parameters for the detection of asthma inflammatory phenotypes.
    Zhang XY, Simpson JL, Powell H, Yang IA, Upham JW, Reynolds PN, Hodge S, James AL, Jenkins C, Peters MJ, Lin JT, Gibson PG.
    Clin Exp Allergy; 2014 Sep 30; 44(9):1137-45. PubMed ID: 24849076
    [Abstract] [Full Text] [Related]

  • 8. Can we predict sputum eosinophilia from clinical assessment in patients referred to an adult asthma clinic?
    Yap E, Chua WM, Jayaram L, Zeng I, Vandal AC, Garrett J.
    Intern Med J; 2013 Jan 30; 43(1):46-52. PubMed ID: 21790924
    [Abstract] [Full Text] [Related]

  • 9. Airway eosinophilia in children with severe asthma: predictive values of noninvasive tests.
    Lex C, Ferreira F, Zacharasiewicz A, Nicholson AG, Haslam PL, Wilson NM, Hansel TT, Payne DN, Bush A.
    Am J Respir Crit Care Med; 2006 Dec 15; 174(12):1286-91. PubMed ID: 16973985
    [Abstract] [Full Text] [Related]

  • 10. "T2-high" in severe asthma related to blood eosinophil, exhaled nitric oxide and serum periostin.
    Pavlidis S, Takahashi K, Ng Kee Kwong F, Xie J, Hoda U, Sun K, Elyasigomari V, Agapow P, Loza M, Baribaud F, Chanez P, Fowler SJ, Shaw DE, Fleming LJ, Howarth PH, Sousa AR, Corfield J, Auffray C, De Meulder B, Knowles R, Sterk PJ, Guo Y, Adcock IM, Djukanovic R, Fan Chung K, on behalf of the U-BIOPRED Study Group.
    Eur Respir J; 2019 Jan 15; 53(1):. PubMed ID: 30578390
    [Abstract] [Full Text] [Related]

  • 11. The use of exhaled nitric oxide concentration to identify eosinophilic airway inflammation: an observational study in adults with asthma.
    Berry MA, Shaw DE, Green RH, Brightling CE, Wardlaw AJ, Pavord ID.
    Clin Exp Allergy; 2005 Sep 15; 35(9):1175-9. PubMed ID: 16164444
    [Abstract] [Full Text] [Related]

  • 12. Diagnosing eosinophilic asthma using a multivariate prediction model based on blood granulocyte responsiveness.
    Hilvering B, Vijverberg SJH, Jansen J, Houben L, Schweizer RC, Go S, Xue L, Pavord ID, Lammers JJ, Koenderman L.
    Allergy; 2017 Aug 15; 72(8):1202-1211. PubMed ID: 28029172
    [Abstract] [Full Text] [Related]

  • 13. Blood eosinophil count is a useful biomarker to identify patients with severe eosinophilic asthma.
    Katz LE, Gleich GJ, Hartley BF, Yancey SW, Ortega HG.
    Ann Am Thorac Soc; 2014 May 15; 11(4):531-6. PubMed ID: 24606022
    [Abstract] [Full Text] [Related]

  • 14. Exploring the effects of omalizumab in allergic asthma: an analysis of biomarkers in the EXTRA study.
    Hanania NA, Wenzel S, Rosén K, Hsieh HJ, Mosesova S, Choy DF, Lal P, Arron JR, Harris JM, Busse W.
    Am J Respir Crit Care Med; 2013 Apr 15; 187(8):804-11. PubMed ID: 23471469
    [Abstract] [Full Text] [Related]

  • 15. Exhaled nitric oxide thresholds associated with a sputum eosinophil count ≥3% in a cohort of unselected patients with asthma.
    Schleich FN, Seidel L, Sele J, Manise M, Quaedvlieg V, Michils A, Louis R.
    Thorax; 2010 Dec 15; 65(12):1039-44. PubMed ID: 20671307
    [Abstract] [Full Text] [Related]

  • 16. Serum periostin in smokers and never smokers with asthma.
    Thomson NC, Chaudhuri R, Spears M, Haughney J, McSharry C.
    Respir Med; 2015 Jun 15; 109(6):708-15. PubMed ID: 25869478
    [Abstract] [Full Text] [Related]

  • 17. Association of serum periostin with aspirin-exacerbated respiratory disease.
    Kim MA, Izuhara K, Ohta S, Ono J, Yoon MK, Ban GY, Yoo HS, Shin YS, Ye YM, Nahm DH, Park HS.
    Ann Allergy Asthma Immunol; 2014 Sep 15; 113(3):314-20. PubMed ID: 25037608
    [Abstract] [Full Text] [Related]

  • 18. Diagnostic utility of inflammatory biomarkers in asthma: exhaled nitric oxide and induced sputum eosinophil count.
    Fortuna AM, Feixas T, González M, Casan P.
    Respir Med; 2007 Nov 15; 101(11):2416-21. PubMed ID: 17714927
    [Abstract] [Full Text] [Related]

  • 19. Clinical characteristics of eosinophilic asthma exacerbations.
    Bjerregaard A, Laing IA, Backer V, Fally M, Khoo SK, Chidlow G, Sikazwe C, Smith DW, Le Souëf P, Porsbjerg C.
    Respirology; 2017 Feb 15; 22(2):295-300. PubMed ID: 27649851
    [Abstract] [Full Text] [Related]

  • 20. Eosinophilic and Neutrophilic Airway Inflammation in the Phenotyping of Mild-to-Moderate Asthma and Chronic Obstructive Pulmonary Disease.
    Górska K, Paplińska-Goryca M, Nejman-Gryz P, Goryca K, Krenke R.
    COPD; 2017 Apr 15; 14(2):181-189. PubMed ID: 27983888
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 49.